Abstract
In the last 20 years, surgery in patients with hemophilia has been carried out with progressively less mortality and morbidity. Even extensive and major surgical operations can be carried out provided that the underlying coagulopathy is corrected and normal hemostasis restored.
We report the results of 196 operations performed in 147 hemophiliacs during the period 1961–1985 in the Department of Surgery, Warsaw Institute of Hematology. Our patients experienced, in this 25-year period, 23% of hemorrhagic complications in hemophilia A and 12.5% in hemophilia B. In the last 5 years, however, the incidence of hemorrhagic complications was reduced to 5.2% in hemophilia A and 8.3% in hemophilia B. This correlates with the discovery of cryoprecipitate and with the development of concentrates of factor VIII and IX, respectively.
In all patients, deficient factor levels were determined before the operation. The replacement therapy was based on the policy of raising the level of factor VIII or IX above 60% of the normal value and maintaining this level above 30% in the postoperative period until final wound healing.
Problems discussed in this article include the principles of replacement therapy, its advantages and disadvantages, and the organization and degree of cooperation among surgeon, hematologist, and blood bank staff.
Résumé
Au cours des 20 dernières années, la chirurgie chez l'hémophile est allée de pair avec une diminution de la mortalité et de la morbidité. Des interventions chirurgicales étendues et majeures ont pu Être pratiquées dés lors que la coagulopathie était corrigée et que l'hémostase normale était rétablie.
Les auteurs rapportent les résultats de 196 opérations pratiquées chez 147 hémophiles de 1961 à 1985 dans le département de chirurgie de l'Institut d'hématologie de Varsovie. Pendant cette période de 25 ans, 23% des patients atteints d'hémophilie A et 12.5% des sujets hémophiliques B ont été victimes de complications hémorragiques. Il est à noter qu'au cours des 5 dernières années, le taux des complications hémorragiques s'est réduit à 5.2% chez les sujets atteints d'hémophilie A et à 8.3% chez les malades atteints d'hémophilie B. Ces résultats sont en corrélation avec la découverte de précipités congelés et avec respectivement le développement des concentrés de facteur VIII et de facteur IX.
Chez tous les malades, les taux déficitaires des différents facteurs furent précisés avant l'intervention. La thérapeutique substitutive fut entreprise de manière à élever le taux des facteurs VIII et IX jusqu'à 60% du taux normal et à la maintenir à 30% de ce taux normal en post-opératoire jusqu'au terme de la cicatrisation définitive.
Les problèmes envisagés dans cet article concernent les principes du traitement substitutif, de ses avantages et de ses inconvénients, de l'organisation et du degré de la coopération qui doit exister entre chirurgien, hématologiste, et équipe de la banque du sang.
Resumen
En el curso de los Últimos 20 años se ha podido realizar cirugía en la hemofilia con una progresiva disminución de la mortalidad y morbilidad. AÚn operaciones muy extensas pueden ser prácticas siempre y cuando la coagulopatia subyacente sea corregida y se logre el restablecimiento de la hemostasis normal.
Se informan los resultados de 196 operaciones realizadas en 147 hemofilíacos en el período 1961–1985 en el Departamento de Cirugía del Instituto de Hematología de Varsovia. En este período de 25 años, nuestros pacientes experimentaron un 23% de complicaciones hemorrágicas en la hemofilia A y un 12.5% en la hemofilia B. Sinembargo, en los Últimos 5 años la incidencia de complicaciones hemorrágicas fue reducido a 5.2% en la hemofilia A y a 8.3% en la hemofilia B. Esto se correlaciona con el descubrimiento del crioprecipitado y el desarrollo de los concentrados de factor VIII y IX, respectivamente.
Los niveles del factor deficiente fueron determinados antes de la operación en la totalidad de los pacientes. La terapia de reemplazo se basó en la política de elevar el nivel del factor VIII o IX por encima de 60% del nivel normal y de mantener tal nivel por encima del 30% en el período postoperatorio y hasta la cicatrización definitiva de la herida.
También se discuten en este artículo otros problemas, tales como la terapia de reemplazo, sus ventajas y desventajas, y la organización y grado de cooperación entre el cirujano, et hematólogo, y el personal del banco de sangre.
Similar content being viewed by others
References
Friedrich, H.: Uber das Operationsrisk bei Hemophilen. Chirurg7:73, 1935
Craddock, C.G., Fenniger, L.P., Simmons, B.: Hemophilia: Problem of surgical intervention for accompanying diseases; Review of the literature and a report of a case. Ann. Surg.128:888, 1948
Pieper, G.R., Perry, S., Borroughs, J.: Surgical intervention in hemophilia. J.A.M.A.170:33, 1959
Rudowski, W.J., Ziemski, J.M.: Extensive surgical procedures in patients with hemophilia A. Surg. Gynecol. Obstet.135:571, 1972
Biggs, R.: Major surgery in haemophilic patients. In Treatment of Haemophilia and Other Coagulation Disorders, R. Biggs, R.G. Macfarlane, editors, Oxford, Blackwell Scientific Publications, 1966, pp. 166–194
Nilsson, I.M., Hedner, U., Ahlberg, Å., Larsson, S.A., Bergentz, S.E.: Surgery of hemophiliacs—20 year's experience. World J. Surg.1:55, 1977
Kitchens, C.S.: Surgery in hemophilia and related disorders. A prospective study of 100 consecutive procedures. Medicine65:34, 1986
Zienkiewicz, K., Kawecka, M., Ortonowski, G., Rudowski, W., Scharf, R., Ziemski, J.M.: Severe respiratory failure in patients with hemophilia A. Abstracts of VII Meeting of the International Society of Hematology, European and African Division, Warsaw, 1985, p. 173
Ziemski, J.M., Lopaciuk, S., Rudowski, W.: Experience gained in 35 operations in patients with hemophilia A. Polish Med. J.43:1269, 1971
Larsson, S.A.: Hemophilia in Sweden. Studies on Demography of Hemophilia and Surgery in Hemophilia and von Willebrand's Disease, Malmo, 1984
Small, M., Steven, M.M., Freeman, P.A., Lowe, G.D., Belch, J.J., Forbes, C.D., Prentice, C.R.: Total knee arthroplasty in haemophilic arthritis. J. Bone Joint Surg.65:163, 1983
Surace, A., Pietrogrande, V.: Total replacement of knee and elbow in hemophilia: Three cases. Int. Surg.65:85, 1983
Scharf, R., Kucharski, W., Rudowski, W.J.: Thoractomy and gastrectomy in patient with severe haemophilia A. Helv. Chir. Acta53:201, 1986
Ziemski, J.M., Kowalski, M., Ortonowski, G., Rudowski, W.J., Misiak, A., Szczepanik, A.B., Scharf, R., Pawlikowski, J.: Spatergebnisse der orthopadischen Eingriffe bei Hamophilie-Patienten. W. Blauth, H.W. Ulrich, editors, Berlin-Heidelberg-New York, Springer-Verlag, 1986
Gomperts, E.D., Malekzadeh, M.H., Finc, R.N.: Dialysis and renal transplant in a hemophiliac. Thromb. Diath. Haemorrh.46:626, 1981
Brockman, S.K., Aprill, S.M., Rabiner, F.S.: Aortic valve replacement in hemophilia: Report of a case. J.A.M.A.222:660, 1972
Tourbach, K.D., Bettigole, R.E., Zizzi, J.A., Subramanian, S., Andersen, M.N.: Coronary bypass in a patient with hemophilia B, or Christmas diease. J. Thorac. Cardiovasc. Surg.77:562, 1979
Stanbridge, R.D.L., Sapsford, R.N., Belcher, P., Smith, K.A., Chipping, P.M.: Correction of double outlet, left ventricle in a patient with hemophilia “A.” J. Cardiovasc. Surg.24:167, 1983
Roskos, R.R., Gilchrist, G.S., Kazmier, F.J., Feldt, R.H., Danielson, G.K.: Management of hemophilia A and B during surgical correction of transposition of the great arteries. Mayo Clin. Proc.58:182, 1983
Leggett, P.L., Doyle, D., Smith, W.B., Culpepper, W., Cooper, S., Ochsner, J.L.: Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies. J. Thorac. Cardiovasc. Surg.87:556, 1984
Brown, B., Steed, D.L., Webster, M.W., Makaroun, M.S., Sperro, J.A., Bontempo, F.A., Raym, M.V., Lewis, J.H.: General surgery in adult hemophiliacs. Surgery99:154, 1986
Ikkala, E., Helske, T., Myllyla, G., Nevanllina, H.R., Pitkanen, P., Rai, V.: Changes in the life expectancy of patients with severe haemophilia A in Finland between 1930–1979. Br. J. Haematol.52:7, 1982
Rizza, C.R., Spooner, R.J.D.: Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976–1980. Br. Med. J.286:929, 1983
Larsson, S.A.: Life expectancy of Swedish haemophiliacs, 1831–1980. Br. J. Haematol.59:593, 1985
Mizumoto, R., Kavarada, Y., Ogura, Y.: Gastrectomy in siblings with Christmas disease. Jpn. J. Surg.10:328, 1980
Post, M., Telfer, M.C.: Surgery in hemophilic patients. J. Bone Joint Surg.57:1137, 1975
Rudowski, W.J.: Major surgery in haemophilia. Ann. R. Coll. Surg. Engl.63:111, 1980
Montane, I., McCollough, N.C., Chun-Yet-Lian, E.: Synovectomy of the knee for hemophylic arthropathy. J. Bone Joint Surg.68A:210, 1986
Kasper, C.K., Dietrich, S.L.: Comprehensive management of haemophilia. Clin. Haematol.14:489, 1985
Allain, J.P.: Transfusion support for haemophiliacs. Clin. Haematol.13:99, 1984
Bona, R.D., Pasquale, D.N., Kalish, R.I., Witten, B.A.: Porcine factor VIII and plasma-pheresis in management of hemophiliac patients with inhibitors. Am. J. Hematol.21:201, 1986
Kay, L., Stainsby, D.S., Buzzard, B., Fearns, M., Hamilton, P.J., Owen, P., Jones, P.: The role of synovectomy in the management of recurrent haemarthroses in haemophilia. Br. J. Haematol.49:53, 1981
Kasper, C.K., Boylen, A.L., Ewing, N.P., Luck, J.V., Dietrich, S.L.: Hematologic management of hemophilia after surgery. J.A.M.A.253:1279, 1985
White, G.C., Taylor, R.E., Blatt, P.M., Roberts, H.R.: Treatment of high titer anti-factor VIII antibody by continuous factor VIII administration: Report of a case. Blood62:141, 1983
Willert, H.G., Horrig, C., Ewald, W., Scharrer, I.: Orthopedic surgery in hemophilic patients. Arch. Orthop. Trauma Surg.101:121, 1983
Arnold, W.D., Hilgartner, M.W.: Hemophilic arthropathy. J. Bone Joint Surg.59:287, 1977
Post, M.: Invited commentary on “Surgery of hemophiliacs—20 years' experience.” World J. Surg.1:67, 1977
Manucci, P.M.: Side effects of antihemophilic concentrates. Scand. J. Haemat. [Suppl.]1:30, 1977
Biggs, R.: Invited commentary on “Surgery of hemophiliacs—20 years' experience.” World J. Surg.1:67, 1977
Fletcher, M.L., Trowell, J.M., Crasks, J., Pavier, J., Rizza, C.R.: Non-A non-B hepatitis after transfusion of factor VIII in frequently treated patients. Br. Med. J.287:1754, 1983
Hay, C.R.M., Triger, D.R., Preston, F.E., Underwood, J.C.E.: Progressive liver disease in haemophilia: An understated problem? Lancet1:1495, 1985
Woodcock, B., Lilleyman, J.: Portal hypertension in severe haemophilia. Lancet1:1388, 1983
Rouzioux, C., Chamaret, S., Montagnier, L., Carnelli, V., Rolland, G., Mannucci, P.M.: Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated factor VIII concentrate. Lancet1:271, 1985
WHO activities for the prevention and control of acquired immunodeficiency syndrome (AIDS). Report of the Director General, Geneva, April 14, 1986, pp. 1–9
Wood, W.I.: Expression of cloned human factor VIII and the molecular basis of gene defects that cause hemophilia. In Transfusion Medicine—Modern Technological Advances, K. Murawski, F. Peetom, editors, New York A.R. Liss, Inc., 1986, pp. 297–302
Buchanan, G.B.: Hemophilia. Pediatr. Clin. North Am.27:309, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rudowski, W.J., Scharf, R. & Ziemski, J.M. Is major surgery in hemophiliac patients safe?. World J. Surg. 11, 378–385 (1987). https://doi.org/10.1007/BF01658122
Issue Date:
DOI: https://doi.org/10.1007/BF01658122